Spondylitis

Common Name(s)

Spondylitis

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Spondylitis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Spondylitis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Spondylitis" returned 1273 free, full-text research articles on human participants. First 3 results:

Ankylosing spondylitis associated with pulmonary arterial hypertension.
 

Author(s): Yao-Min Hung, Chin-Chang Cheng, Shue-Ren Wann, Shoa-Lin Lin

Journal: Intern. Med.. 2015 ;54(4):431-4.

 

Pulmonary arterial hypertension (PAH) is a frequent complication of connective tissue diseases, such as systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis. However, the occurrence of PAH in a patient with ankylosing spondylitis (AS) has not been previously reported ...

Last Updated: 9 Mar 2015

Go To URL
Xinfeng capsule improves pulmonary function in ankylosing spondylitis patients via NF-ΚB-iNOS-NO signaling pathway.
 

Author(s): Jian Liu, Yajun Qi, Li Zheng, Yunxiang Cao, Lei Wan, Wenfang Ye, Li Fang

Journal: J Tradit Chin Med. 2014 Dec;34(6):657-65.

 

To study changes in the nuclear factor-κB p65 (NF-κB p65)-inducible nitric oxide synthase (iNOS)-nitric oxide (NO) signaling pathway and the effects of Xinfeng capsules (XFC) in patients with ankylosing spondylitis (AS).

Last Updated: 26 Jan 2015

Go To URL
Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study.
 

Author(s): Tugba Tuylu, Ismail Sari, Dilek Solmaz, Didem Leyla Kozaci, Servet Akar, Necati Gunay, Fatos Onen, Nurullah Akkoc

Journal: Clinics (Sao Paulo). 2014 Dec;69(10):688-93.

 

New bone formation is one of the hallmark characteristics of ankylosing spondylitis, which is thereby associated with syndesmophytes. Fetuin-A is a molecule that is abundantly found in calcified tissues and it shows high affinity for calcium phosphate minerals and related compounds. ...

Last Updated: 18 Dec 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Spondylitis" returned 90 free, full-text review articles on human participants. First 3 results:

[Genetics of ankylosing spondylitis].
 

Author(s): Patricia Castro-Santos, Miguel A Gutiérrez, Roberto Díaz-Peña

Journal: Rev Med Chil. 2014 Sep;142(9):1165-73.

 

Ankylosing spondylitis (AS) is a prototypical inflammatory disease of the locomotor system affecting axial skeleton. It is part of the general group of spondyloarthopathies (SpA). Its strong association with histocompatibility antigen HLA-B27 is known since 1973. However, HLA-B27 ...

Last Updated: 18 Dec 2014

Go To URL
Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis.
 

Author(s): Petra Baji, Márta Péntek, Sándor Szántó, Pál Géher, László Gulácsi, Orsolya Balogh, Valentin Brodszky

Journal: Eur J Health Econ. 2014 May;15 Suppl 1():S45-52.

 

To compare the efficacy and safety of infliximab-biosimilar with other biological drugs for the treatment of active ankylosing spondylitis (AS).

Last Updated: 6 Jun 2014

Go To URL
Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis.
 

Author(s): Fernanda Genre, Raquel López-Mejías, José A Miranda-Filloy, Begoña Ubilla, Beatriz Carnero-López, Ricardo Blanco, Trinitario Pina, Carlos González-Juanatey, Javier Llorca, Miguel A González-Gay

Journal: Biomed Res Int. 2014 ;2014():860651.

 

Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease associated with accelerated atherosclerosis and increased risk of cardiovascular (CV) disease. AS patients also display a high prevalence of features clustered under the name of metabolic syndrome (MeS). Anti-TNF- ...

Last Updated: 23 Apr 2014

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Progression of Spinal Fusion in Ankylosing Spondylitis
 

Status: Recruiting

Condition Summary: Spondylitis, Ankylosing

 

Last Updated: 11 Nov 2014

Go to URL
European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study
 

Status: Not yet recruiting

Condition Summary: Ankylosing Spondylitis

 

Last Updated: 27 Jan 2011

Go to URL